skip to content
Detailed Quote
5i Report

Review of Andlauer Healthcare Group

AUG 17, 2021 - One of Canada’s leading supply chain management partner specializing in third-party logistics and delivery solutions for the healthcare sector trades at multiples lower than the 2-year averages. Coverage initiated with a 'B' rating.

Download Report
Company Profile
Interactive Chart
Key Ratios
Analyst Recommendations
5i Recent Questions

Q: Hello 5i team,
I initiated a position in AND around the time you published a report on the company. The reasons were because of the niche market, growing dividend, partially involved in healthcare, and growth (although slowly).

A few questions:
-brief opinion on the most recent quarter(released March 2nd)?
-The one and only report was in 2021, would you be having one coming up?
-Would AND be a stock that you would add to one of the portfolios in the future?


Read Answer Asked by Andrew on March 06, 2023

Q: Hi,

Can you provide general comments on D2L's latest earnings release please?
Specifically, any concerns about their 3 month and 9 month adjusted EBITDA (loss) and their updated financial outlook? Other released financial metrics appear to be positive.
Is this still a long term buy?

What is your take on Andlauer's early warning report released Dec 7, ie..."agreements to sell an aggregate of up to 1,760,000 subordinate voting shares in the capital of the Company ("Subordinate Voting Shares"), representing approximately 9.64% of the issued and outstanding Subordinate Voting Shares, for investment purposes."
Almost 10% is quite a lot of shares is it not?
Is this still a long term buy?

I don't currently own any of these shares but they are on my short term watchlist.


Read Answer Asked by Stephen on December 09, 2022
Share Information
News and Media